Navigating consent management in life sciences & pharma
A one-page guide for marketing and commercial leaders
Your brand plans, launches and omnichannel campaigns all depend on one thing: HCPs who have said yes. OptInsight helps you grow that number and put it to work.

Consented reach is your real ceiling
Every commercial plan assumes you can reach your target HCPs. In practice, most pharma companies are allowed to email only 10–30% of them. That gap limits launch impact, campaign ROI and the return on your field force. Growing consented reach is one of the fastest ways to get more from what you already invest.

What holds commercial teams back
- Too few HCPs to activate: campaigns and content reach only a fraction of the target list.
- Consent stuck in silos: reps, events, websites and agencies each hold their own piece, so no one sees the full picture.
- Lost opportunities: outdated or unsynced consent leads to missed contacts, or to contacts you shouldn’t make.
- Unclear what works: no view of which channels and campaigns actually earn permission.

What you gain
01
More reach
Grow the share of target HCPs you are allowed to engage, around 60% instead of the usual 10–30%.
02
Higher campaign ROI:
Spend goes to HCPs who want to hear from you, on their preferred channel and topic.
03
Stronger launches
Build a consented audience before launch, not after.
04
Less dependence on the field
Collect consent at scale without relying on reps, KAMs and MSLs.
05
Confidence across markets
One approach that works in every country, so teams act without second-guessing.

What it takes
- One source of truth: consent from every channel in one place, linked to your CRM and marketing tools.
- Always up to date: a yes or an opt-out is reflected everywhere, immediately.
- HCP in control: a preference centre where HCPs choose topics, channels and frequency.
- Insight into what works: see which channels, campaigns and content drive consent.
Checklist for marketing and commercial leaders
- Do we know what share of our target HCPs we may contact, per channel and country?
- Is consented reach a KPI in our brand and launch plans?
- Can our teams act on consent directly in CRM and marketing tools
- Do we know which channels and campaigns earn the most permission?
- Are we growing consent without adding work for the field force?

How OptInsight helps
Consent-as-a-Service: our platform plus managed services that run consent campaigns for you, in every market. You get consented HCPs, ready to activate.


Key features of our consent management solution for omnichannel and marketing
- Multi-Channel Consent Sources: Track consent from all channels, online and offline
- Preference Center: Offer individuals control over their interests and communication preferences
- UTM Consent Tracking: Identify which content and channels drive consent and engagement

Final thought
Consent is more than a checkbox it’s a communication contract. Omnichannel success in pharma depends on making consent intelligent, dynamic, and user-centric.
”Consent is more than a checkbox. It's the licence to engage, and it decides how far your commercial plans can reach.

Martijn van den Corput
Co-founder and CEO OptInsight
Curious?
Schedule a meeting with us.
Tip: involve your colleagues from other departments within your company. In this way we can instantly answer questions and provide clarity from various points of view.


